Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting publishing date : 2021 - 04 - 09 save search
Volaris announces summons for general ordinary annual shareholders' meeting
Published: 2021-04-09 (Crawled : 21:00) - prnewswire.com
VLRS | $7.8 -0.64% 0.0% 490K
|
Transportation
| Email alert
Add to watchlist
Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting
Published: 2021-04-09 (Crawled : 15:00) - biospace.com/
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: 1.99%
H: 0.0%
C: -5.73%
cancer research
Turning Point Therapeutics Announces New Preclinical Data for Three Drug CandidatesPresentations Planned at Annual Meeting of American Association for Cancer Research, Held Virtually April 9-14
Published: 2021-04-09 (Crawled : 15:00) - biospace.com/
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: -3.32%
presentation cancer drug research preclinical pre-clinical
S&P Global's 2021 Annual Meeting of Shareholders to be held on May 5
Published: 2021-04-09 (Crawled : 14:15) - prnewswire.com
SPGI | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
|
| O: 0.22%
H: 0.79%
C: 0.74%
Sana Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2021
Published: 2021-04-09 (Crawled : 13:15) - globenewswire.com
SANA | $7.605 -1.62% -1.64% 3.4M
|
|
| O: -0.34%
H: 0.0%
C: -2.03%
cancer biotech research technology iot preclinical pre-clinical
aTyr Pharma Presents Preclinical Research Showing Effects of ATYR2810 in Lung and Breast Cancer at the 2021 AACR Virtual Annual Meeting
Published: 2021-04-09 (Crawled : 13:00) - biospace.com/
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -1.62%
H: 9.18%
C: 5.88%
cancer research breast cancer preclinical pre-clinical
ChemoCentryx’s Oral PD-L1 inhibitor, CCX559, Featured in Poster Presentation at the 2021 American Association for Cancer Research (AACR) Annual Meeting
Published: 2021-04-09 (Crawled : 13:00) - globenewswire.com
CCXI | $51.99 -0.04%
|
Health Technology
|
| O: -0.77%
H: 2.22%
C: 1.37%
presentation cancer research
Rubius Therapeutics Presents Initial Clinical Results from the Ongoing Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors at the American Association of Cancer Research Virtual Annual Meeting
Published: 2021-04-09 (Crawled : 12:15) - globenewswire.com
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: -0.08%
H: 2.65%
C: -0.95%
solid tumors ongoing phase 1 results cancer research trial phase 3 phase 2
Novocure Announces 26 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2021 Suggesting Broad Applicability of Tumor Treating Fields
Published: 2021-04-09 (Crawled : 12:00) - novocure.com
NVCR | $12.09 0.33% 0.33% 850K
|
Health Technology
|
| O: -1.14%
H: 0.92%
C: 0.82%
presentation cancer research
Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During American Association for Cancer Research (AACR) 2021 Annual Meeting
Published: 2021-04-09 (Crawled : 12:00) - biospace.com/
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
|
| O: 0.73%
H: 0.06%
C: -4.28%
cancer research iot
Kymera Therapeutics to Present New Results from Non-Interventional Study in Patients with Hidradenitis Suppurativa at the Society for Investigative Dermatology (SID) 2021 Annual Meeting
Published: 2021-04-09 (Crawled : 12:00) - globenewswire.com
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: -1.11%
H: 0.03%
C: -3.35%
results
Surface Oncology Presents Promising Preclinical Data for Lead Immunotherapy Product Candidates at the American Association for Cancer Research Annual Meeting
Published: 2021-04-09 (Crawled : 12:00) - globenewswire.com
SURF | $1.07 -0.93% -1.41% 0
|
Health Technology
|
| O: 0.12%
H: 1.0%
C: -2.81%
immunotherapy therapy cancer research preclinical pre-clinical
Hansa Biopharma: Notice to Annual General Meeting - Apr 09, 2021
Published: 2021-04-09 (Crawled : 10:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.18%
H: 0.79%
C: 0.57%
biopharma
Hansa Biopharma: Notice to Annual General Meeting
Published: 2021-04-09 (Crawled : 07:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.18%
H: 0.79%
C: 0.57%
biopharma
Bonso Announces Receipt of Nasdaq Notice of Deficiency for Failure to Hold an Annual Meeting of Shareholders
Published: 2021-04-09 (Crawled : 01:00) - globenewswire.com
BNSO | $1.12 0.85% 23K
|
Consumer Durables
|
| O: -9.2%
H: 23.04%
C: 4.68%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.